Effects of Combined High Intensity Interval Training and Resistance Training (Hypertension)
Effects of Combined High Intensity Interval Training and Resistance Training on Body Composition, Blood Pressure, and Cardiorespiratory Fitness in Obese Hypertensive Men
Background: Hypertension has long been considered as a major risk factor for cardiovascular disease representing a high public health concern.
Objectives: the purpose of this study is to evaluate the effects of combined HIIT and resistance training on body composition, blood pressure, and cardiorespiratory fitness in obese hypertensive men.
Methods: This study will make use of sixty obese hypertensive men aged 40 to 60 years. All participants meeting the eligibility criteria will be assigned to one of three groups; combined HIIT and resistance group, HIIT only group or control group. Combined exercise group subjects will undergo weekly three sessions of both HIIT and resistance training for sixteen weeks. The HIIT session will involve four four-minute high-intensity intervals with an intensity of at 80-95% of the HRmax interspersed with two-minute active recovery intervals with intensity of 40% to 60% of the HRmax. The resistance training session will be composed of eight exercises perform 3 sets of 8-12 repetitions with an intensity of 80% of the subject's estimated 1-RM. The HIIT only group perform 12 weeks of HIIT only. The control group subjects will be instructed not to change their usual daily physical activities routine and instructed to abstain from practicing any exercise regimens during the 12-week study period. Body composition measures, blood pressure and VO2peak will be assessed at baseline and at the end of the study period.
Results: All the outcome variables will be assessed at baseline and 12 weeks following the treatment period.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Ahmed S Ahmed, PhD
- Phone Number: 00966115886326 000966564347031
- Email: a.aseil@psau.edu.sa
Study Locations
-
-
Alkharj
-
Riyadh, Alkharj, Saudi Arabia, 16278
- Recruiting
- Prince Sattam Bin Abdulaziz University
-
Contact:
- Ahmed Sayed Ahmed
- Phone Number: +966564347031
- Email: a.aseil@psau.edu.sa
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- men aged between 40 and 60 years old,
- have been diagnosed with clinical stage 1 or 2 hypertension,
- being obese with body mass index more than 30 kg/m2
- physically inactive
Exclusion Criteria:
- musculoskeletal problems that may limit their ability to participate in resistance or HIIT programs
- diabetes mellitus
- a history of respiratory or chronic heart disease
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: study group
Combined exercise group subjects will undergo weekly three sessions of both HIIT and resistance training for sixteen weeks.
The HIIT session will involve four four-minute high-intensity intervals with an intensity of at 80-95% of the HRmax interspersed with two-minute active recovery intervals with intensity of 40% to 60% of the HRmax.
The resistance training session will be composed of eight exercises perform 3 sets of 8-12 repetitions with an intensity of 80% of the subject's estimated 1-RM.
The HIIT only group perform 12 weeks of HIIT only.
|
Combined exercise group subjects will undergo weekly three sessions of both HIIT and resistance training for sixteen weeks.
The HIIT session will involve four four-minute high-intensity intervals with an intensity of at 80-95% of the HRmax interspersed with two-minute active recovery intervals with intensity of 40% to 60% of the HRmax.
|
|
Other: control group
The control group subjects will be instructed not to change their usual daily physical activities routine and instructed to abstain from practicing any exercise regimens during the 12-week study period.
|
The control group subjects will be instructed not to change their usual daily physical activities routine and instructed to abstain from practicing any exercise regimens during the 12-week study period.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
blood pressure in mmhg
Time Frame: 12 weeks
|
12 weeks
|
|
peak oxygen consumption in ml/kg/min
Time Frame: 12 weeks
|
12 weeks
|
|
body weight in Kg
Time Frame: 12 weeks
|
12 weeks
|
|
body mass index in kg/m2
Time Frame: 12 weeks
|
12 weeks
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SCBR-430/2025
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.